Phase 1 Gout Clinical Trials
7 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–7 of 7 trials
Recruiting
Phase 1
Drug-Drug Interaction Study of ABP-671 in Gout Patients
GoutGout ChronicDDI (Drug-Drug Interaction)
Atom Therapeutics Co., Ltd20 enrolled1 locationNCT07367971
Recruiting
Phase 1
A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.
Gout
Shanghai Institute Of Biological Products36 enrolled1 locationNCT06298071
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011
Acute Gout Flare
Innovent Biologics (Suzhou) Co. Ltd.64 enrolled1 locationNCT07295496
Recruiting
Phase 1
Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia
GoutHyperuricemia
Shenyang Sunshine Pharmaceutical Co., LTD.60 enrolled1 locationNCT06629376
Completed
Phase 1
A drug-drug interaction trial between AR882, fluconazole, carbamazepine, celecoxib, and sulfasalazine in healthy particpants
Gout
Arthrosi Therapeutics Australia Pty, Ltd a subsidiary of Arthrosi Therapeutics, Inc54 enrolled2 locationsACTRN12623001038684
Completed
Phase 1
Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study of AR882 in Healthy Adult Male Volunteers
Chronic goutHyperuricemia
Arthrosi Therapeutics Australia Pty, Ltd a subsidiary of Arthrosi Therapeutics, Inc.50 enrolled1 locationACTRN12619000908134
Completed
Phase 1
Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Rising Dose Study of AR882 in Healthy Adult Male Volunteers
Chronic goutHyperuricemia
Arthrosi Therapeutics Australia Pty, Ltd a subsidiary of Arthrosi Therapeutics, Inc.72 enrolled1 locationACTRN12619000021178